What's new

Human medicines European public assessment report (EPAR): Dupixent, dupilumab, Date of authorisation: 26/09/2017, Revision: 41, Status: Authorised

Human medicines European public assessment report (EPAR): Dupixent, dupilumab, Date of authorisation: 26/09/2017, Revision: 41, Status: Authorised

Apr 1, 2025 - 14:49
 0
Human medicines European public assessment report (EPAR): Dupixent, dupilumab, Date of authorisation: 26/09/2017, Revision: 41, Status: Authorised
Human medicines European public assessment report (EPAR): Dupixent, dupilumab, Date of authorisation: 26/09/2017, Revision: 41, Status: Authorised
Read More

Tags:

Previous Article

Human medicines European public assessment report (EPAR): Zubsolv, buprenorphine...

Next Article

Pickle startup closes pre-seed funding round

Related Posts

Human medicines European public assessment report (EPAR): Omvoh, mirikizumab, Date of authorisation: 26/05/2023, Revision: 4, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 9, 2025  0

EMEA-002141-PIP01-17-M04

EMEA-002141-PIP01-17-M04

Mar 14, 2025  0

Minutes of the Cancer Medicines Forum - December 2024

Mar 11, 2025  0